The company owns and operates office, multifamily and hotel property and has been shifting toward apartments. Published coverage of the second-quarter results said management is moving toward a pure-play multifamily focus, including the sale of its lending business. Multifamily occupancy stood at 95.3% on …
The Singapore company sells MEDIFLY medical-grade sterile blowfly larvae for wound debridement and received FDA 510(k) clearance for MEDIFLY Maggots on June 15, 2026. A public offering closed on September 17, 2026, with the underwriter's over-allotment closing on September 29, though its size was …
Curis is a biotechnology company whose lead asset is emavusertib, an oral IRAK4 and FLT3 inhibitor in Phase 2 studies for relapsed hematologic cancers. It is being tested with ibrutinib in relapsed or refractory primary CNS lymphoma and with zanubrutinib in chronic lymphocytic leukemia. …
The company sells apparel through several brands, direct to consumers and wholesale, and its AVO collegiate licensingBrandis the growth focus. On July 8, 2026 it forecast Q3 revenue of USD 8.5 million to USD 11.0 million and said the figure excluded USD 8 million …
The release carried several items. Enovix cited an initial purchase order for 100,000 batteries from a multinational dual-use drone provider and a first production order for its MX1-B01 drone cell, with deliveries starting in early 2027. It will spend USD 19 million to double …
Erayak designs and sells power products such as inverters, generators, chargers and portable power stations through subsidiaries in China, the UK, Mexico, Poland and Portugal. In 2025 it set up a U.S. subsidiary, Nexora Group, and in 2026 it promoted tri-fuel generators and backup …
The company lowered its 52-week outlook again. Net sales are now seen at USD 5.016 billion to USD 5.063 billion from USD 5.070 billion to USD 5.142 billion, and adjusted EPS at USD 0.63 to 0.68 from USD 0.75 to 0.85. The midpoint of …
The company is developing Revita, an endoscopic procedure aimed at helping patients keep weight off after stopping GLP-1 drugs. Earlier one-year randomized data showed patients keeping about 80% of GLP-1 weight loss versus 46% on sham, and open-label results were about 78%. A published …
Key HighlightsGlobavend Holdings (NASDAQ:GVH) was trading up 8.53% at USD 0.9291 in pre-market on Friday, November 13, 2026, according to pre-market market data, and no company announcement dated November 11 to November 13 was found.Fiscal 2025Revenuewas USD 23.56 million, up 42.46%, whileEarningsfell 48.99% to …
The company announced on October 16, 2026 that Nasdaq had written to it on October 15, 2026. Its shares had closed below the USD 1 minimum for 30 consecutive business days, breaching the listing rule. To regain compliance, GreenPower Motor (NASDAQ:GP) must close at …